Does DABIGATRAN Cause Vascular stent thrombosis? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Vascular stent thrombosis have been filed in association with DABIGATRAN. This represents 0.2% of all adverse event reports for DABIGATRAN.
5
Reports of Vascular stent thrombosis with DABIGATRAN
0.2%
of all DABIGATRAN reports
1
Deaths
5
Hospitalizations
How Dangerous Is Vascular stent thrombosis From DABIGATRAN?
Of the 5 reports, 1 (20.0%) resulted in death, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Vascular stent thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN Cause?
Gastrointestinal haemorrhage (210)
Hypotension (167)
Atrial fibrillation (150)
Drug interaction (143)
Haemorrhage (141)
Anaemia (131)
Dizziness (123)
Acute kidney injury (120)
Drug ineffective (118)
Fall (117)
What Other Drugs Cause Vascular stent thrombosis?
TICAGRELOR (700)
CLOPIDOGREL BISULFATE (506)
ASPIRIN (379)
HEPARIN (178)
PRASUGREL (159)
RIVAROXABAN (95)
BIVALIRUDIN (63)
TIROFIBAN (63)
APIXABAN (32)
ENOXAPARIN (32)
Which DABIGATRAN Alternatives Have Lower Vascular stent thrombosis Risk?
DABIGATRAN vs DABIGATRAN ETEXILATE
DABIGATRAN vs DABRAFENIB
DABIGATRAN vs DABRAFENIB\TRAMETINIB
DABIGATRAN vs DACARBAZINE
DABIGATRAN vs DACLATASVIR